4.3 Article

Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus

Journal

MOLECULAR AND CELLULAR NEUROSCIENCE
Volume 65, Issue -, Pages 58-67

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mcn.2015.02.014

Keywords

Epilepsy; AII; Losartan; Microglia; Cognitive impairment; Neuronal loss

Categories

Funding

  1. Xi'an Jiaotong University Campus Fund [0203222, 76]

Ask authors/readers for more resources

Neuroinflammation plays a role in the pathology of epilepsy and in cognitive impairment. Angiotensin II (AT1) and the angiotensin receptor type 1 (AII) have been shown to regulate seizure susceptibility in different models of epilepsy. Inhibition of All attenuates neuroinflammatoty responses in different neurological diseases. In the present study, we showed that the protein expression of All and All was increased in activated microglia following lithium pilocarpine-induced status epilepticus (SE) in rats. Furthermore, the All receptor antagonist, losartan, significantly inhibited SE-induced cognitive impairment and microglia-mediated inflammation. Losartan also prevented SE induced neuronal loss in the hippocampus and exerted neuroprotection. These data suggest that losartan improves SE-induced cognitive impairment by suppressing microglia mediated inflammatory responses and attenuating hippocampal neuronal loss. Overall, our findings provide a possible therapeutic strategy for the treatment of cognitive impairment in epilepsy. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available